{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:57:45Z","timestamp":1783306665001,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Facial Plastic Surgery Clinics of North America"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.fsc.2006.10.005","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T07:16:43Z","timestamp":1172042203000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Sculptra (Injectable Poly-L-Lactic Acid)"],"prefix":"10.1016","volume":"15","author":[{"given":"Sanjay P.","family":"Keni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Sidle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.fsc.2006.10.005_bib1","first-page":"369","article-title":"Relationship between lipoatrophy and quality of life","volume":"15","author":"Echavez","year":"2005","journal-title":"AIDS Read"},{"issue":"5","key":"10.1016\/j.fsc.2006.10.005_bib2","first-page":"9","article-title":"Poly-L-lactic acid as a facial filler","volume":"10","author":"Sterling","year":"2005","journal-title":"Skin Therapy Lett"},{"issue":"11 Pt 2","key":"10.1016\/j.fsc.2006.10.005_bib3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2310\/6350.2005.31237","article-title":"HIV facial lipoatrophy: causes and treatment options","volume":"31","author":"Jones","year":"2005","journal-title":"Dermatol Surg"},{"issue":"10","key":"10.1016\/j.fsc.2006.10.005_bib4","first-page":"1279","article-title":"Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial","volume":"30","author":"Jones","year":"2004","journal-title":"Dermatol Surg"},{"issue":"9","key":"10.1016\/j.fsc.2006.10.005_bib5","first-page":"5","article-title":"Approaches to treatment of HIV facial lipoatrophy","volume":"10","author":"Jones","year":"2005","journal-title":"Skin Therapy Lett"},{"issue":"6","key":"10.1016\/j.fsc.2006.10.005_bib6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.otohns.2006.01.005","article-title":"Contemporary surgical management of HIV-associated facial lipoatrophy","volume":"134","author":"Funk","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.fsc.2006.10.005_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00128071-200405050-00010","article-title":"Poly-L-lactic acid","volume":"5","author":"Perry","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"17","key":"10.1016\/j.fsc.2006.10.005_bib8","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.fsc.2006.10.005_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"},{"issue":"9","key":"10.1016\/j.fsc.2006.10.005_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/jbm.820270904","article-title":"Tissue response and in vivo degradation of selected polyhydroxy acids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB\/VA)","volume":"27","author":"Gogolewski","year":"1993","journal-title":"J Biomed Mater Res"},{"issue":"2","key":"10.1016\/j.fsc.2006.10.005_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jbm.820070204","article-title":"Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat","volume":"7","author":"Brady","year":"1973","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.fsc.2006.10.005_bib12","unstructured":"Engelhard PKM. Safety and efficacy of New-Fill (polylactic acid) in the treatment of HIV-associated lipoatrophy of the face (HALF). Presented at the XIV International AIDS Conference 2002. Barcelona, Spain, July 7\u201312, 2002."},{"key":"10.1016\/j.fsc.2006.10.005_bib13","first-page":"36","article-title":"Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy","volume":"9","author":"Mest","year":"2004","journal-title":"Antiviral Ther"},{"issue":"2","key":"10.1016\/j.fsc.2006.10.005_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","article-title":"Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy","volume":"52","author":"Burgess","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.fsc.2006.10.005_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.qai.0000152834.02912.98","article-title":"Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients","volume":"38","author":"Lafaurie","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.fsc.2006.10.005_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archderm.142.3.329","article-title":"Use of\u00a0polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy","volume":"142","author":"Cattelan","year":"2006","journal-title":"Arch Dermatol"},{"issue":"7 Pt 1","key":"10.1016\/j.fsc.2006.10.005_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00042728-200507000-00009","article-title":"NewFill for skin augmentation: a new filler or failure?","volume":"31","author":"Beljaards","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.fsc.2006.10.005_bib18","unstructured":"(BPU) DL (injectable poly-L-lactic acid). Prescribing information. Dermik Laboratories, Berwyn (PA): August, 2004."},{"issue":"3\u20134","key":"10.1016\/j.fsc.2006.10.005_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14764170500451404","article-title":"Safety of Sculptra: a review of clinical trial data","volume":"7","author":"Engelhard","year":"2005","journal-title":"J Cosmet Laser Ther"}],"container-title":["Facial Plastic Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740606001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740606001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:19:37Z","timestamp":1761020377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064740606001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1064740606001040"],"URL":"https:\/\/doi.org\/10.1016\/j.fsc.2006.10.005","relation":{},"ISSN":["1064-7406"],"issn-type":[{"value":"1064-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sculptra (Injectable Poly-L-Lactic Acid)","name":"articletitle","label":"Article Title"},{"value":"Facial Plastic Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fsc.2006.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}